Nifedipina Alter (Nifedipine)

Nifedipine blocks L‑type calcium channels on vascular smooth muscle and cardiac cells. This inhibition prevents calcium from entering the cells, leading to relaxation of arterial walls, vasodilation, and a decrease in peripheral resistance. The resulting effect lowers blood pressure and reduces the heart's workload, which alleviates angina and improves peripheral blood flow.

The specific dose of Nifedipina Alter is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other factors. Healthcare professionals tailor the regimen to achieve optimal blood‑pressure control or angina relief while minimizing side effects.

Safety of nifedipine in pregnancy or while nursing has not been fully established. It should only be used if the potential therapeutic benefit justifies any possible risk to the fetus or infant. Physicians will evaluate the risk‑benefit profile before prescribing to pregnant or lactating patients.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Nifedipine belongs to the calcium‑channel blocker class, which differs from ACE inhibitors, ARBs, or beta‑blockers in its mechanism of causing direct vasodilation. Compared with other antihypertensives, it provides rapid blood‑pressure reduction and is especially useful when patients have concomitant angina or Raynaud's phenomenon. Choice of therapy depends on individual patient profiles and comorbidities.

Nifedipina Alter should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, and store it out of direct sunlight. Do not refrigerate or freeze the tablets, as temperature extremes can affect stability.

Nifedipina Alter is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare professional. Dosing frequency and timing are set by the prescriber based on the therapeutic goal and patient response.

Serious risks include severe hypotension, myocardial infarction, atrioventricular block, and rare cases of hepatotoxicity or severe allergic reactions. Patients should be monitored for signs of chest pain, fainting, rapid heartbeat, or skin rash, and seek immediate medical attention if any of these occur.

Nifedipina Alter is contraindicated in patients with known hypersensitivity to nifedipine or any other calcium‑channel blocker, those with severe aortic stenosis, and individuals who have experienced a serious reaction to the drug previously. Clinicians should also exercise caution in patients with significant liver impairment or unstable cardiac conditions.